Functional Neurological Disorders in Patients Admitted in Stroke Units

Functional Neurological Disorders Clinical Trial

— NEUROFON  

Official title:

Functional Neurological Disorders in Patients Admitted in Stroke Units: Clinical Profile et and 6 Months Follow-up

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT04662372
• Other study ID #: SBY_2020_1
• Status: Recruiting
• Start date: March 5, 2021
• Est. completion date: September 2025

Study information

• Verified date: June 2024
• Source: Fondation Ophtalmologique Adolphe de Rothschild
• Contact: Amelie Yavchitz, PhD
• Phone: 01 48 03 64 54
• Email: ayavchitz[@]for.paris
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

Functional neurological disorders are an important subgroup of patients with stroke mimics admitted to stroke unit.Their clinical profile and outcome are poorly known. The goal of this study is to describe the cognitive and behavioral profile of stroke mimics patients, without evidence of neurological disease.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 20
• Est. completion date: September 2025
• Est. primary completion date: September 2025
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Age over 18 years old

• Patients admitted in stroke unit for a neurological deficit, without evidence of neurovascular or othe neurological disease.

• NIHSS = 1 at time of admission

• Informed and consent patient to study

• Health insured

Exclusion Criteria:

• Patient receiving legal protection

• Pregnant or breastfeeding woman

Related Conditions & MeSH terms

• Conversion Disorder
• Functional Neurological Disorders
• Nervous System Diseases

Intervention

Other:
• Description
description of the cognitive and behavioral profile of stroke mimics patients, without evidence of neurological disease.

Locations

Country	Name	City	State
France	Hopital Fondation Adolphe de Rothschild	Paris

Sponsors (1)

Lead Sponsor	Collaborator
Fondation Ophtalmologique Adolphe de Rothschild

Country where clinical trial is conducted

France, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Patient characteristics	Cognitive/behavioural characteristics of patients assessed for stroke using the National Institute of Health Stroke Score ranging from 0 to 42 (0: no stroke; 1-4: minor stroke; 5-15: moderate stroke; moderate to severe stroke; 21-42: severe stroke)	3 months
Secondary	symptoms of patients	Description of symptoms at 3 and 6 months after transition in stroke unit	3 and 6 months